digital health startups weight loss glp-1 Dr. Craig Primack talks Hims & Hers launching its own offering as demand rises Beyond the Hype: Where and

Individuals without diabetes but with multiple cardiovascular risk factors were also included where defined as high cardiovascular risk in the original trials

With that, we used our DuPuis process to create the name Pivit that captures the idea that a small pivot in your life can change your health and wellness trajectory

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

Nourish, pace the ramp, and use evidence-based scalp support

Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management